Jaguar Health, Inc. (JAGX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 20.27M | 3.23M | 3.08M | 2.98M | 2.21M | 3.51M | 3.11M | 2.72M | 2.35M | 2.3M | 2.81M | 2.68M | 1.97M | 3.26M | 3.15M | 2.92M | 2.63M | 2.08M | 630K | 385K |
| Revenue Growth % | 815.63% | -7.81% | -0.8% | 9.48% | -5.83% | 52.57% | 10.49% | 1.68% | 19.22% | -29.45% | -10.7% | -8.39% | -24.88% | 56.73% | 400% | 658.7% | 111.52% | -19.25% | -77.28% | -87.84% |
| Cost of Goods Sold | 1.16M | 2.2M | 532K | 527K | 515K | 557K | 541K | 427K | 430K | 687K | 514K | 491K | 345K | 495K | 613K | 456K | 455K | 469K | 617K | 664K |
| COGS % of Revenue | 5.71% | 68.01% | 17.26% | 17.69% | 23.26% | 15.87% | 17.41% | 15.69% | 18.29% | 29.87% | 18.27% | 18.35% | 17.49% | 15.18% | 19.46% | 15.61% | 17.33% | 22.55% | 97.94% | 172.47% |
| Gross Profit | 19.11M | 1.03M | 2.55M | 2.45M | 1.7M | 2.95M | 2.57M | 2.29M | 1.92M | 1.61M | 2.3M | 2.19M | 1.63M | 2.77M | 2.54M | 2.46M | 2.17M | 1.61M | 13K | -279K |
| Gross Margin % | 94.29% | 31.99% | 82.74% | 82.31% | 76.74% | 84.13% | 82.59% | 84.31% | 81.71% | 70.13% | 81.73% | 81.65% | 82.51% | 84.82% | 80.54% | 84.39% | 82.67% | 77.45% | 2.06% | -72.47% |
| Gross Profit Growth % | 1025.01% | -64.94% | -0.62% | 6.89% | -11.56% | 83.01% | 11.66% | 4.99% | 18.07% | -41.66% | -9.38% | -11.36% | -25.02% | 71.63% | 19415.38% | 983.51% | 229.79% | -9.85% | -99.35% | -113.06% |
| Operating Expenses | 8.93M | 21.48M | 9.79M | 10.46M | 11.12M | 11.11M | 9.83M | 9.49M | 10.14M | 9.17M | 11.09M | 10.29M | 11.47M | 9.05M | 12.43M | 8.94M | 13.92M | 12.43M | 9.54M | 11.3M |
| OpEx % of Revenue | 44.06% | 663.89% | 317.52% | 351.09% | 502.26% | 316.59% | 316.25% | 348.81% | 431.14% | 398.7% | 394.1% | 384.42% | 581.74% | 277.64% | 394.7% | 306.2% | 530.44% | 597.74% | 1514.6% | 2935.32% |
| Selling, General & Admin | 5M | 5.31M | 6.13M | 7.19M | 7.39M | 6.58M | 5.79M | 5.84M | 5.82M | 5.07M | 5M | 6.01M | 6.7M | 4.74M | 6.49M | 6.49M | 8.98M | 6.95M | 6.23M | 7.26M |
| SG&A % of Revenue | 24.68% | 164.02% | 198.86% | 241.49% | 333.79% | 187.38% | 186.16% | 214.55% | 247.72% | 220.57% | 177.92% | 224.59% | 339.6% | 145.4% | 206.13% | 222.29% | 342.06% | 334.18% | 988.89% | 1885.45% |
| Research & Development | 3.93M | 14.31M | 3.66M | 3.27M | 3.73M | 4.53M | 4.04M | 3.65M | 4.31M | 3.46M | 6.08M | 4.28M | 4.78M | 4.31M | 5.94M | 2.45M | 4.95M | 5.48M | 3.31M | 3.87M |
| R&D % of Revenue | 19.38% | 442.44% | 118.65% | 109.6% | 168.47% | 129.21% | 130.08% | 134.25% | 183.41% | 150.57% | 216.17% | 159.83% | 242.14% | 132.24% | 188.57% | 83.91% | 188.38% | 263.56% | 525.71% | 1005.19% |
| Other Operating Expenses | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 634K | 0 | 26K | -12K | 0 | 0 | 0 | 0 | 0 | -20K | 172K |
| Operating Income | 10.18M | -20.44M | -7.24M | -8.01M | -9.42M | -8.16M | -7.26M | -7.2M | -8.21M | -7.56M | -8.79M | -8.1M | -9.85M | -6.29M | -9.9M | -6.48M | -11.75M | -10.82M | -9.53M | -11.58M |
| Operating Margin % | 50.23% | -631.9% | -234.77% | -268.78% | -425.52% | -232.46% | -233.66% | -264.5% | -349.43% | -328.57% | -312.37% | -302.77% | -499.24% | -192.82% | -314.16% | -221.81% | -447.77% | -520.29% | -1512.54% | -3007.79% |
| Operating Income Growth % | 208.08% | -150.61% | 0.33% | -11.25% | -14.68% | -7.94% | 17.36% | 11.17% | 16.56% | -20.22% | 11.21% | -25.05% | 16.24% | 41.91% | -3.85% | 44.05% | -34.09% | -109.44% | -77.28% | -37.03% |
| EBITDA | 8.72M | -19.9M | -6.68M | -7.45M | -8.88M | -7.56M | -6.67M | -6.64M | -7.61M | -7.05M | -8.16M | -7.48M | -9.29M | -5.68M | -9.31M | -5.83M | -11.3M | -10.33M | -9.06M | -11.15M |
| EBITDA Margin % | 43.03% | -615.12% | -216.7% | -250.12% | -400.86% | -215.56% | -214.48% | -243.95% | -323.48% | -306.74% | -290.15% | -279.56% | -471.3% | -174.36% | -295.52% | -199.62% | -430.44% | -496.63% | -1437.46% | -2895.84% |
| EBITDA Growth % | 198.29% | -163.08% | -0.22% | -12.25% | -16.7% | -7.21% | 18.33% | 11.27% | 18.17% | -24.12% | 12.32% | -28.3% | 17.74% | 44.98% | -2.79% | 47.7% | -35.56% | -118.12% | -90.49% | -42.1% |
| D&A (Non-Cash Add-back) | 0 | 543K | 557K | 556K | 546K | 593K | 596K | 559K | 610K | 502K | 625K | 621K | 551K | 602K | 587K | 648K | 455K | 492K | 473K | 431K |
| EBIT | 8.72M | -29.26M | -7.24M | -8.01M | -9.42M | -16.35M | -7.26M | -7.2M | -8.76M | -7.19M | -8.79M | -8.1M | -10.22M | -5.6M | -9.88M | -6.85M | -13.97M | -11.88M | -10.11M | -12.07M |
| Net Interest Income | -699K | 0 | 0 | 15K | 56K | 110K | 162K | 108K | -611K | -248K | -500K | -3.45M | -2.18M | -2.63M | -2.73M | -2.54M | -4.19M | -2.43M | -2.08M | -2.01M |
| Interest Income | 0 | 0 | 0 | 15K | 56K | 110K | 162K | 108K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 699K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 611K | 248K | 500K | 3.45M | 2.18M | 2.63M | 2.73M | 2.54M | 4.19M | 2.43M | 2.08M | 2.01M |
| Other Income/Expense | -1.46M | -2.75M | -2.41M | -2.55M | -1.18M | -2.08M | -2.76M | -2.43M | -1.15M | -1.75M | 883K | -4.19M | -2.55M | -1.95M | -2.71M | -2.91M | -6.41M | -3.5M | -2.66M | -2.5M |
| Pretax Income | 8.72M | -23.19M | -9.65M | -10.56M | -10.6M | -10.23M | -10.02M | -9.63M | -9.37M | -9.31M | -7.9M | -12.29M | -12.4M | -8.23M | -12.61M | -9.39M | -18.16M | -14.32M | -12.19M | -14.08M |
| Pretax Margin % | 43.03% | -716.94% | -312.94% | -354.48% | -478.59% | -291.65% | -322.43% | -353.84% | -398.47% | -404.74% | -280.98% | -459.3% | -628.65% | -252.52% | -400.29% | -321.47% | -691.96% | -688.37% | -1935.24% | -3657.4% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 8.85M | -23.06M | -9.5M | -10.41M | -10.46M | -9.92M | -9.85M | -9.49M | -9.23M | -9.17M | -7.78M | -12.15M | -12.2M | -7.58M | -12.52M | -9.37M | -17.99M | -14.31M | -12.19M | -14.08M |
| Net Margin % | 43.65% | -712.86% | -308.21% | -349.35% | -472.63% | -282.7% | -317.05% | -348.84% | -392.43% | -398.7% | -276.5% | -454.04% | -618.76% | -232.55% | -397.46% | -320.68% | -685.18% | -688.13% | -1935.24% | -3657.4% |
| Net Income Growth % | 184.57% | -132.47% | 3.57% | -9.64% | -13.42% | -8.18% | -26.69% | 21.88% | 24.39% | -20.96% | 37.88% | -29.71% | 32.16% | 47.03% | -2.69% | 33.48% | -49.77% | -63.22% | -55% | -52.42% |
| Net Income (Continuing) | 8.72M | -23.19M | -9.65M | -10.56M | -10.6M | -10.23M | -10.02M | -9.63M | -9.37M | -9.31M | -7.9M | -12.29M | -12.4M | -8.23M | -12.61M | -9.39M | -18.16M | -14.32M | -12.19M | -14.08M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -1.57M | -1.4M | -1.27M | -1.11M | -952K | -791K | -514K | -328K | -180K | -64K | 56K | 191K | 310K | -699K | -48K | 41K | 64K | 242K | 0 | 0 |
| EPS (Diluted) | -13.60 | -116.40 | -219.78 | -358.94 | -584.44 | -657.03 | -920.18 | -3535.11 | -3049.20 | -6581.92 | -19689.00 | -36178.00 | -125372.00 | -180061.00 | -463483.00 | -462774.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 |
| EPS Growth % | 97.67% | 82.28% | 76.12% | 89.85% | 80.83% | 90.02% | 95.33% | 90.23% | 97.57% | 96.34% | 95.75% | 92.18% | 92.08% | 83.87% | 55.74% | 62.6% | -40.04% | 3.39% | 56.89% | 76.39% |
| EPS (Basic) | -13.60 | -116.40 | -219.78 | -358.94 | -584.44 | -657.03 | -920.18 | -3535.11 | -3049.20 | -6581.92 | -19689.00 | -36178.00 | -125372.00 | -180061.00 | -463483.00 | -462774.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 |
| Diluted Shares Outstanding | 515.79K | 199.33K | 43.23K | 28.99K | 17.9K | 15.1K | 10.71K | 2.69K | 3.02K | 1.39K | 395 | 336 | 97 | 42 | 27 | 20 | 11 | 13 | 12 | 11 |
| Basic Shares Outstanding | 515.79K | 199.33K | 43.23K | 28.99K | 17.9K | 15.1K | 10.71K | 2.69K | 3.02K | 1.39K | 395 | 336 | 97 | 42 | 27 | 20 | 11 | 13 | 12 | 11 |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |